Mark L. Pacala, Director: Starling Oncology STLN Buy · Filed 25/03/28

Trade details

Type: Insider buy
Amount: $94,184.48
Shares · price: 90,562 sh · $1.04 a share
Held after: 224,971 sh
Stock: Starling Oncology STLN
Person: Mark L. PacalaDirector
Trade date: 25/03/26
Filed: 25/03/28
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 8 insiders
Holding change: +67.4%

Starling Oncology trades, last 26 weeks

What else happened in Starling Oncology around then

Filed or reported within 30 days of the trade day · 25/02/24~25/04/25

Mark L. Pacala's recent trades

Mark L. PacalaDirector
SellStarling Oncology
Sell
Starling Oncology
STLN
$186.5K
46,630 sh
$186.5K
Filed 25/11/20
Traded 25/11/18
Mark L. PacalaDirector
SellStarling Oncology
Sell
Starling Oncology
STLN
$4,840
1,210 sh
$4,840
Filed 25/11/20
Traded 25/11/18
Mark L. PacalaDirector
SellStarling Oncology
Sell
Starling Oncology
STLN
$8,640
2,160 sh
$8,640
Filed 25/11/20
Traded 25/11/18
Mark L. PacalaDirector
Planned saleStarling Oncology
Planned sale
Starling Oncology
STLN
$200K
50,000 sh
$200K
Filed 25/11/18
Traded 25/11/18